Table 2 Characteristics of participants. To facilitate comparison of the study population at recruitment and after the intervention, % are calculated within condition (control-leaflet; treatment-application) and study stages (at recruitment; post-intervention)
At recruitment (n = 473) | Post-intervention (n = 312) | |||
|---|---|---|---|---|
Control | Treatment | Control | Treatment | |
n = 248 | n = 225 | n = 176 | n = 136 | |
Age, mean (median) | 45.3 (42.5) | 43 (44) | 46.4 (45.5) | 44.7 (47) |
Gender, n (%) | ||||
- Female | 131 (52.8) | 118 (52.4) | 94 (53.4) | 65 (47.8) |
- Male | 117 (47.2) | 106 (47.1) | 82 (46.6) | 70 (51.5) |
- Other | 0 | 1 (0.4) | 0 | 1 (0.7) |
Education (highest level achieved), n (%) | ||||
- Elementary school | 57 (23) | 41 (18.2) | 39 (22.2) | 27 (19.9) |
- High or professional school | 93 (37.5) | 97 (43.1) | 60 (34.1) | 53 (39) |
- University level | 98 (39.5) | 87 (38.7) | 77 (43.8) | 56 (41.2) |
Recruitment location, n (%) | ||||
- Emergency waiting room | 219 (88.3) | 205 (91.1) | 154 (87.5) | 123 (90.4) |
- Primary care waiting room | 27 (10.9) | 19 (8.4) | 20 (11.4) | 13 (9.6) |
- NA | 2 (0.8) | 1 (0.4) | 2 (1.1) | 0 |
Medication (nb of daily drugs taken), n (%) | ||||
- 0 drugs | 120 (48.3) | 109 (48.4) | 89 (50.6) | 65 (47.8) |
- 1–2 drugs | 71 (28.6) | 78 (34.7) | 50 (28.4) | 52 (38.2) |
- 3–4 drugs | 34 (13.7) | 27 (12) | 19 (10.8) | 13 (9.6) |
- 5–9 drugs | 17 (6.85) | 9 (4) | 13 (7.4) | 6 (4.4) |
- 10 and more | 6 (2.4) | 2 (0.8) | 5 (2.8) | 0 |
Medical consultations (nb of medical consultations in a year), mean (median) | 4.99 (2) | 3.97 (2) | 4.98 (2) | 3.78 (2) |